MK-677 vs NAC for appetite
Short answer: For appetite, more users report improvement with NAC — 91% of 34 reports, versus 66% of 228 for MK-677.
MK-677 has 0 meta-analyses and 15 randomized trials on PubMed; NAC has 387 and 767.
Based on 978 reports about MK-677 and 2,058 about NAC. Not medical advice.
| MK-677 Substance | NAC Supplement | |
|---|---|---|
| Users say it helped | 39%helped479 reports · high confidence | 54%helped947 reports · high confidence |
| Verdict | Mixed | Mixed |
| Research | BResearch: Moderate | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 15 | 387 / 767 |
| Mainly used for | ||
| Mood % reporting improvement | 52% (21) | 65% (323) |
| Anxiety % reporting improvement | 4% (27) | 90% (301) |
| Appetite % reporting improvement | 66% (228) | 91% (34) |
| Sleep % reporting improvement | 79% (170) | 71% (48) |
| Focus % reporting improvement | 0% (3) | 81% (170) |
| Common side effects | water retention, fatigue, stomach issues, hunger | anhedonia, stomach issues, depression, emotional blunting |
| Typical dose reported | 12.5 mg / before dinner | 600 mg |
“From my own experience (also have suffered from poor sleep), i experienced a noticeable increase in sleep quality even with a low dose.”
Taken together, these preliminary findings suggest that dietetic approaches might be included as part of BD treatment. Also considering the high risk of metabolic disorders in individuals with BD, they should be encouraged to choose healthy dietary lifestyles, including daily intake of fruits, vegetables, seafood and whole grains.
Nutr Neurosci, 2023 ↗“NAC has helped me stay calm and reduce anxiety as well as gives me loads of energy if I am sleep deprived.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate